GAMMA Investing »

Monte Rosa Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $367 52 7.06

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
Aisling Capital Management
Alphabet
Citadel Advisors
Casdin Capital
Caption Management
Charles Schwab Investment Management
TD Asset Management
Candriam Luxembourg S.C.A.
Bank of New York Mellon
Bank of America Corporation

View all funds holding Monte Rosa Therapeutics